Intellectual Property Cases filed in Delaware
Cases 11 - 20 of 72
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., et al.
as 1:2019cv00315
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01699
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2018cv01562
Plaintiff: AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Defendant: Mylan Inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv01777
Plaintiff: Noven Pharmaceuticals, Inc.
Defendant: Mylan Technologies Inc. , Mylan Pharmaceuticals Inc. , Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv00322
Plaintiff: UCB, Inc. , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Defendant: Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant: Mylan Pharmaceuticals, Inc. , Mylan Technologies, Inc. and Mylan, Inc.
Counter_defendant: LTS Lohmann Therapie-Systeme AG , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv00249
Plaintiff: Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc.
Defendant: Mylan Pharmaceuticals Inc. , Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00113
Plaintiff: Amgen Inc.
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00024
Plaintiff: Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddys Laboratories, Ltd. et al We have downloadable decisions or orders for this case
as 1:2016cv01267
Plaintiff: Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd , Teva Neuroscience, Inc. and others
Defendant: Doctor Reddys Laboratories, Ltd., Doctor Reddys Laboratories, Inc., Sandoz, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Amneal Pharmaceuticals et al We have downloadable decisions or orders for this case
as 1:2016cv00853
Defendant: Aurobindo Pharma Ltd, Cadila Healthcare Ltd. doing business as Zydus Cadila, Hetero USA Inc. and others
Plaintiff: Amgen Inc.
3Rd Party Defendant: Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Counter Claimant: Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?